DNAJB1 and neoplasm: In FL-HCC, the DNAJB1-PRKACA fusion transcript is detectable in 100% of patients and has been identified as the oncogenic driver in tumor pathogenesis25,26 indicating expression of the fusion transcript in all tumor cells.